These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28288577)

  • 21. Molecular surveillance of multidrug-resistant Gram-negative bacteria in Ukrainian patients, Germany, March to June 2022.
    Schultze T; Hogardt M; Velázquez ES; Hack D; Besier S; Wichelhaus TA; Rochwalsky U; Kempf VA; Reinheimer C
    Euro Surveill; 2023 Jan; 28(1):. PubMed ID: 36695452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of multidrug-resistant organisms in refugee patients admitted to a German university hospital depending on duration of stay in Germany.
    Reinheimer C; Abdollahi P; Zacharowski K; Meybohm P; Mutlak H; Klingebiel T; Wichelhaus TA; Kempf VAJ
    GMS Hyg Infect Control; 2019; 14():Doc07. PubMed ID: 31293878
    [No Abstract]   [Full Text] [Related]  

  • 23. Multidrug-resistant organisms detected in refugee patients admitted to a University Hospital, Germany June‒December 2015.
    Reinheimer C; Kempf VA; Göttig S; Hogardt M; Wichelhaus TA; O'Rourke F; Brandt C
    Euro Surveill; 2016; 21(2):. PubMed ID: 26794850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of surveillance cultures to detect gastrointestinal colonization with multidrug-resistant gram-negative bacteria.
    Snyder GM; D'Agata EM
    Am J Infect Control; 2012 Jun; 40(5):474-6. PubMed ID: 21925768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections.
    MacVane SH
    J Intensive Care Med; 2017 Jan; 32(1):25-37. PubMed ID: 26772199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multidrug-resistant organisms (MDRO) in patients in outpatient care in the Rhine-Main region, Germany, in 2014: Prevalence and risk factors].
    Neumann N; Mischler D; Cuny C; Hogardt M; Kempf VA; Heudorf U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Feb; 59(2):292-300. PubMed ID: 26631014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decline of multidrug-resistant Gram negative infections with the routine use of a multiple decontamination regimen in ICU.
    Camus C; Sauvadet E; Tavenard A; Piau C; Uhel F; Bouju P; Letheulle J; Dollo G; Gacouin A; Lavoué S; Le Tulzo Y
    J Infect; 2016 Sep; 73(3):200-9. PubMed ID: 27373765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidrug resistant Gram-negative infections in neonatology.
    Berberian G; Brizuela M; Rosanova MT; Travaglianti M; Mastroiani A; Reijtman V; Fiorili G; Santa Cruz D; Castro G
    Arch Argent Pediatr; 2019 Feb; 117(1):6-11. PubMed ID: 30652440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease.
    Ferstl PG; Filmann N; Brandt C; Zeuzem S; Hogardt M; Kempf VAJ; Müller M; Waidmann O; Reinheimer C
    Liver Int; 2017 Oct; 37(10):1488-1496. PubMed ID: 28374901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of antimicrobial resistance in Germany : What is the current situation?].
    Maechler F; Geffers C; Schwab F; Peña Diaz LA; Behnke M; Gastmeier P
    Med Klin Intensivmed Notfmed; 2017 Apr; 112(3):186-191. PubMed ID: 28378152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
    Kader AA; Kumar AK
    Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Change in hospital antibiotic use and acquisition of multidrug-resistant gram-negative organisms after the onset of coronavirus disease 2019.
    Bork JT; Leekha S; Claeys K; Seung H; Tripoli M; Amoroso A; Heil EL
    Infect Control Hosp Epidemiol; 2021 Sep; 42(9):1115-1117. PubMed ID: 33298211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and risk factors of MRSA, ESBL and MDR bacterial colonization upon admission to an Egyptian medical ICU.
    Fouda R; Soliman MS; ElAnany MG; Abadeer M; Soliman G
    J Infect Dev Ctries; 2016 Apr; 10(4):329-36. PubMed ID: 27130993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of carbapenem-resistant organisms and other Gram-negative MDRO in German ICUs: first results from the national nosocomial infection surveillance system (KISS).
    Maechler F; Peña Diaz LA; Schröder C; Geffers C; Behnke M; Gastmeier P
    Infection; 2015 Apr; 43(2):163-8. PubMed ID: 25395161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased multi-drug resistance among the elderly on admission to the hospital--a 12-year surveillance study.
    Denkinger CM; Grant AD; Denkinger M; Gautam S; D'Agata EM
    Arch Gerontol Geriatr; 2013; 56(1):227-30. PubMed ID: 22682422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug-resistant Gram-negative bacteria in postoperative infections.
    Singh AV; Mishra B; Thakur A
    J Indian Med Assoc; 2009 Mar; 107(3):148-50, 163. PubMed ID: 19810380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of multidrug-resistant Gram-negative infections in children.
    Hsu AJ; Tamma PD
    Clin Infect Dis; 2014 May; 58(10):1439-48. PubMed ID: 24501388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multidrug-Resistant Organisms (MDRO) in Rehabilitation Clinics in the Rhine-Main-District, Germany, 2014: Prevalence and Risk Factors].
    Heudorf U; Färber D; Mischler D; Schade M; Zinn C; Cuny C; Nillius D; Herrmann M
    Rehabilitation (Stuttg); 2015 Oct; 54(5):339-45. PubMed ID: 26505186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of resistant microbes in critical care units is transient, despite an unrestricted formulary and multiple antibiotic trials.
    Franklin GA; Moore KB; Snyder JW; Polk HC; Cheadle WG
    Surg Infect (Larchmt); 2002; 3(2):135-44. PubMed ID: 12519480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.